Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacand and Zoloft in Late-Life Depression
NCT01794455Phase 4
Key facts
- Status
- Terminated
- Start
- May 2013
- Primary completion
- Mar 2015
- Countries
- 1
- Sponsor
- Vanderbilt University
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Drugs
- candesartan
- Conditions
- major depressive disorder (MDD)
01
Overview
Phase 4, open-label trial of candesartan in major depressive disorder (MDD), sponsored by Vanderbilt University. Primary endpoint: MRI Arterial Spin Labeling Perfusion at 8 weeks. Started May 2013; status: terminated.
02
Design
- Study design
- Non-randomizedOpen-labelSingle group
03
Endpoints
Primary
MRI Arterial Spin Labeling Perfusion
Beyond the preview
Go deeper on NCT01794455.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794455.